Back
Keros Therapeutics Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
60
KROS
Keros Therapeutics
Last Price:
60.76
Seasonality Move:
38.45%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.Keros Therapeutics Price Quote
$60.76
+0.62 (+1.03%)
(Updated: October 30, 2024 at 2:25 PM ET)
Keros Therapeutics Key Stats
Buy
60
Keros Therapeutics (KROS)
is a Buy
Day range:
$58.99 - $60.72
52-week range:
$27.31 - $73.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7,300.62
P/B ratio:
5.36%
Volume:
250.4K
Avg. volume:
334.9K
1-year change:
117.43%
Market cap:
$2.3B
Revenue:
$151K
EPS:
$-5.13
How Much Does Keros Therapeutics Make?
-
How Much Are Keros Therapeutics's Sales Annually?
KROS Revenues are $151K -
How Much Profit Does Keros Therapeutics's Make A Year?
KROS net income is -$153M
Is Keros Therapeutics Growing As A Company?
Data Unavailable
Keros Therapeutics Stock Price Performance
-
Did Keros Therapeutics Stock Go Up Last Month?
Keros Therapeutics share price went up by 6.54% last month -
Did KROS's Share Price Rise Over The Last Year?
KROS share price rose by 117.43% over the past 1 year
What Is Keros Therapeutics 52-Week High & Low?
-
What Is Keros Therapeutics’s 52-Week High Share Price?
Keros Therapeutics has traded as high as $73.00 over the past 52 weeks -
What Is Keros Therapeutics’s 52-Week Low Share Price?
Keros Therapeutics has traded as low as $27.31 over the past 52 weeks
Keros Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Keros Therapeutics?
-
How Much Debt Does Keros Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Keros Therapeutics Have?
Cash and short term investments quarterly total is $405.9M -
What Is Keros Therapeutics’s Book Value Per Share?
Book value per share is 11.64
Is Keros Therapeutics Cash Flow Positive?
-
What Is KROS Cash Flow From Operations?
Cash flow from operations (TTM) is -$143.8M -
What Is Keros Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $229.9M -
What Is Keros Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3M
Keros Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
KROS return on invested capital is -45.94% -
What Is Keros Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -42.15% -
What Is KROS Return On Equity?
ROE is a measure of profitability and is -45.94%
Keros Therapeutics Earnings Date & Stock Price
-
What Is Keros Therapeutics's Stock Price Today?
A single share of KROS can be purchased today for 60.14 -
What Is Keros Therapeutics’s Stock Symbol?
Keros Therapeutics trades on the nasdaq under the ticker symbol: KROS -
When Is Keros Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Keros Therapeutics is scheduled on November 6, 2024 -
When Is KROS's next ex-dividend date?
Keros Therapeutics's next ex-dividend date is October 30, 2024 -
How To Buy Keros Therapeutics Stock?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Keros Therapeutics Competitors
-
Who Are Keros Therapeutics's Competitors?
Below is a list of companies who compete with Keros Therapeutics or are related in some way:
Keros Therapeutics Dividend Yield
-
What Is KROS Dividend Yield?
Keros Therapeutics’s dividend yield currently is 0% -
What Is Keros Therapeutics’s Payout Ratio?
Keros Therapeutics’s payout ratio is 0% -
When Did Keros Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 30, 2024 -
What Is Keros Therapeutics’s Dividend Per Share?
Keros Therapeutics pays a dividend of $0.00 per share
Keros Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0.2% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 89.33 |
| Upside from Last Price: | 48.54% |